Each row is an authorised trial looking for participants. The plain-language title is written by our editorial team, and underneath it you can see the original registry title — so you can check for yourself that we did not change the meaning. We cannot tell you whether you are eligible, and we do not publish the hospital name: the international registry does not carry it, and a wrong name would send you to a room where nobody expects you. For the centre and the team's contact details, open the official record.
Trials recruiting now
0 of 7 titles have been rewritten in plain language by our editorial team. The rest still show the registry's protocol wording.
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
A treatment is being testedPhase 3
Running in: Institutul Clinic Fundeni, București · Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul de Oncologie Sf Nectarie SRL, Craiova · Institutul Regional de Oncologie Iasi, Iași · Spitalul Municipal Ploiesti, Ploiești · SC Oncomed SRL, Timișoara
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A treatment is being testedPhase 3
Running in: Centrul Medical Unirea SRL, Brașov · Spitalul Memorial Baneasa, București · Institutul Oncologic 'Prof Dr. Ion Chiricuta' Cluj-Napoca, Cluj-Napoca · Clinica de Oncologie Sf Nectarie, Craiova · Institutul Regional de Oncologie Iasi, Iași · Pelican Impex SRL, Oradea
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A treatment is being testedPhase 2
Running in: Fundeni Clinical Institute, București · Institutul Regional de Gastroenterologie și Hepatologie Prof. Dr. Octavian Fodor, Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie", Craiova · Floresti/ Cluj · S.C. Centrul de Oncologie Euroclinic S.R.L., Iași
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
A treatment is being testedPhase 3
Running in: Fundeni Clinical Institute-Medical Oncology ( Site 1504), București · Institutul Oncologic Cluj ( Site 1502), Cluj-Napoca · Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1500), Craiova · Institutul Regional de Oncologie ( Site 1505), Iași
The counts are read automatically from ClinicalTrials.gov and show trials marked there as recruiting, with at least one site in Romania. We do not verify each one by hand, and we cannot guarantee that a trial marked “recruiting” is still taking patients today — the registry lags behind what happens in the hospital. For any decision, the official record and your doctor have the final word.
